We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Calls FDA’s Fourth ANDA Stability Test Time Point an Overreach
GPhA Calls FDA’s Fourth ANDA Stability Test Time Point an Overreach
November 6, 2013
GPhA wants the FDA to eliminate a proposed requirement that ANDA sponsors submit an additional, fourth stability time point for accelerated testing conditions, which the group says is not consistent with international regulations.